Raymond James Financial Services Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,900
| Closed | -$4.53K | – | 3345 |
|
|
2023
Q2 | $4.53K | Sell |
13,900
-300
| -2% | -$98 | ﹤0.01% | 3215 |
|
|
2023
Q1 | $6.11K | Buy |
+14,200
| New | +$6.11K | ﹤0.01% | 3226 |
|
|
2019
Q4 | – | Sell |
-15,486
| Closed | -$117K | – | 2906 |
|
|
2019
Q3 | $117K | Buy |
15,486
+2,164
| +16% | +$16.3K | ﹤0.01% | 2606 |
|
|
2019
Q2 | $181K | Buy |
+13,322
| New | +$181K | ﹤0.01% | 2561 |
|